Renovia was formed to develop and commercialize products for better first-line diagnosis and treatment to improve the condition-specific quality of life for millions of women with pelvic floor disorders. Renovia's technology enables treatment via precise visualization of pelvic movement in real-time during pelvic floor muscle training, while monitoring usage and progress over time. As a women's health organization, Renovia is in pursuit of scalable and cost-effective care for pelvic floor disorders delivered through the power of digital health.
Date | Amount | Type | Investors | Valuation |
---|---|---|---|---|
09/24/18 | $42,300,000 | Series B |
Ascension Health Ventures Cormorant Asset Management Inova Strategic Investments Longwood Fund OSF Ventures Perceptive Advisors Western Technology Investment | undisclosed |